News
1d
GlobalData on MSNFDA approves KalVista’s Ekterly for hereditary angioedemaThe US Food and Drug Administration (FDA) has approved KalVista Pharmaceuticals' Ekterly (sebetralstat) as the first and only ...
Orsini, a leader in rare disease pharmacy solutions, has been chosen by KalVista Pharmaceuticals as a specialty pharmacy ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results